Inozyme Pharma, Inc. (INZY) Earnings
|
Expand Research on INZY
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -4.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +61.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/25  |
Q225 | N/A | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/14/25 | Q125 | -$0.44 | -$0.40 | -$0.04 | N/A | N/A | N/A |  | | Details | |
| 5/13/25 |
Q125 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/20/25 |
Q424 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/24 | Q324 | -$0.39 | -$0.44 | +$0.05 | N/A | N/A | N/A | | | Details | |
| 8/7/24 | Q224 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/24 | Q224 | -$0.44 | -$0.40 | -$0.04 | N/A | N/A | N/A | | | Details | |
| 5/7/24 | Q124 | -$0.38 | -$0.35 | -$0.03 | N/A | N/A | N/A | | | Details |
